# AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
> **ANDA207712** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-04-28
## Drug
- **FDA Application Number:** ANDA207712
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
- **Generic name:** AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
- **Active ingredients:** AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp.
- **First approval:** 2017-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207712)
---
*AI Analytics · CC0 1.0*